~~<i id='D8A47B07FA'><strike id='D8A47B07FA'><tt id='D8A47B07FA'><pre id='D8A47B07FA'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

explore

author：Wikipedia 2025-09-06 03:28:15 - browse：94

Trump Campaign Event In Nevada — Ethan Miller/Getty Images

WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.

In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.

“Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How to save PrEP access — and even expand it
Next article： The Supreme Court will review a ruling striking down a domestic violence federal gun ban

focus

explore

focus

MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

WSS

Will the market for weight loss drugs really reach $100 billion?

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

Medicare proposal to cover medical devices draws a mixed reaction

What to do when lifesaving products contribute to climate change

Medicare proposal to cover medical devices draws a mixed reaction

Rep. Raul Ruiz on the physician shortage and more

leisure time

explore

focus

As demand for Covid shots wanes, Moderna seeks its next success

Guidelines to prevent youth baseball injuries need more muscle

Dobbs anniversary: the lost opportunity of abortion as health care

U.K. Biobank has 500,000 peoples' genome sequences available

New air purifier tech could be key to improving indoor air quality

Rep. Raul Ruiz on the physician shortage and more

In age of alternative facts, a scholarly course on calling out crap

With clinical trial data readouts, here's how to spot spin

Jerome Adams on the need for new antivirals for Covid

Pediatric cancer treatments threatened by a new FDA policy

focus

Organ aging and disease risk measured by new blood test

FDA investigates CAR

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

Alkermes shareholders re

Drug repurposing or repositioning? The language matters

After affirmative action ruling, medical educators look to 'holistic review'

explore

explore

focus

focus